Your Article Summary
See Latest ArticlesProtox Appoints Dr. Alexander Giaquinto to Board of Directors
Protox Therapeutics , 06/17/09
Protox Therapeutics Inc. , a leader in the development of receptor targeted fusion proteins, announced that it has appointed Dr. Alexander R. Giaquinto to its Board of Directors. Dr. Giaquinto is currently the Senior Vice President of Regulatory Affairs and Quality Assurance for Regado Biosciences Inc. and acts as an independent consultant to several pharmaceutical companies.
Today in Execs on the Move...keeping you current
Receive free subspecialty "5-minute updates" via email
Bristol-Myers Squibb Announces Appointment of Charles Bancroft as Acting Chief Financial Officer
Bristol Myers-Squibb Company, 12/15/09
AHIMA Selects its Leader
HealthDataManagement, 12/14/09
Robert J. Bertolini Elected to Genzyme's Board of Directors
Genzyme, 12/09/09